Cefepime/Enmetazobactam for Complicated Urinary Tract Infections
Author:
Affiliation:
1. Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina
2. Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore
Publisher
American Medical Association (AMA)
Subject
General Medicine
Link
https://jamanetwork.com/journals/jama/articlepdf/2796968/jama_advani_2022_ed_220073_1664214361.86695.pdf
Reference15 articles.
1. Current challenges in the treatment of complicated urinary tract infections and prostatitis.;Wagenlehner;Clin Microbiol Infect,2006
2. In Vitro activity of cefepime-enmetazobactam against gram-negative isolates collected from US and European hospitals during 2014-2015.;Morrissey;Antimicrob Agents Chemother,2019
3. Beyond piperacillin-tazobactam: cefepime and AAI101 as a potent ß-lactam-ß-lactamase inhibitor combination.;Papp-Wallace;Antimicrob Agents Chemother,2019
4. Effect of cefepime/enmetazobactam vs piperacillin/tazobactam on clinical cure and microbiological eradication in patients with complicated urinary tract infection or acute pyelonephritis: a randomized clinical trial.;Kaye;JAMA
5. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.;Gupta;Clin Infect Dis,2011
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cefepime-Induced Encephalopathy in Patients Treated for Urinary Tract Infection;Cureus;2024-07-22
2. Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis;Open Forum Infectious Diseases;2024-07-16
3. Cefepime/Enmetazobactam: First Approval;Drugs;2024-05-18
4. Multidisciplinary Exploration of Unknown Oral Lesions With Accompanying Oral Verrucas of the Tongue: A Case Report;Cureus;2024-02-25
5. Cefepime–Taniborbactam in Complicated Urinary Tract Infection;New England Journal of Medicine;2024-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3